Omnicell Deferred Long Term Liab vs Capital Stock Analysis

OMCL Stock

USD 45.96 0.27 0.59%

Omnicell financial indicator trend analysis is much more than just breaking down Omnicell prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Omnicell is a good investment. Please check the relationship between Omnicell Deferred Long Term Liab and its Capital Stock accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.

Deferred Long Term Liab vs Capital Stock

Deferred Long Term Liab vs Capital Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Omnicell Deferred Long Term Liab account and Capital Stock. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Omnicell's Deferred Long Term Liab and Capital Stock is -0.55. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Capital Stock in the same time period over historical financial statements of Omnicell, assuming nothing else is changed. The correlation between historical values of Omnicell's Deferred Long Term Liab and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Omnicell are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Deferred Long Term Liab i.e., Omnicell's Deferred Long Term Liab and Capital Stock go up and down completely randomly.

Correlation Coefficient

-0.55

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Capital Stock

The total amount of a company's capital funded by shareholders through the issue and subscription of shares.

Most indicators from Omnicell's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Omnicell current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.Selling General Administrative is expected to rise to about 487.6 M this year, although the value of Tax Provision will most likely fall to (2.8 M).

	2021	2022	2023	2024 (projected)
Gross Profit	554.7M	589.0M	496.8M	521.7M
Total Revenue	1.1B	1.3B	1.1B	1.2B

Gross Profit Total Revenue

Omnicell fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Total Assets		0.87	0.9	0.81	0.99	0.55	0.97	0.96	0.73	0.98	0.76	0.86	0.99	0.71	0.96	0.85	0.94	-0.39	0.65	0.77	0.85	0.91	0.94	0.98	0.99	0.87
Short Long Term Debt Total	0.87		0.85	0.67	0.83	0.3	0.81	0.79	0.53	0.81	0.52	0.91	0.83	0.43	0.89	0.91	0.7	-0.43	0.58	0.7	0.8	0.64	0.93	0.85	0.88	0.8
Other Current Liab	0.9	0.85		0.65	0.87	0.23	0.87	0.84	0.71	0.86	0.57	0.79	0.89	0.46	0.89	0.79	0.84	-0.17	0.4	0.83	0.86	0.79	0.96	0.85	0.91	0.89
Total Current Liabilities	0.81	0.67	0.65		0.79	0.59	0.75	0.72	0.65	0.8	0.83	0.61	0.84	0.73	0.8	0.61	0.73	-0.26	0.55	0.46	0.41	0.75	0.74	0.77	0.8	0.56
Total Stockholder Equity	0.99	0.83	0.87	0.79		0.55	0.98	0.95	0.64	0.99	0.77	0.85	0.98	0.73	0.9	0.84	0.94	-0.47	0.71	0.78	0.79	0.91	0.9	1.0	0.94	0.87
Other Liab	0.55	0.3	0.23	0.59	0.55		0.47	0.66	0.58	0.59	0.75	0.23	0.6	0.65	0.48	0.23	0.65	-0.54	0.72	0.11	0.33	0.69	0.29	0.54	0.53	0.23
Property Plant And Equipment Net	0.97	0.81	0.87	0.75	0.98	0.47		0.91	0.61	0.97	0.72	0.85	0.95	0.73	0.88	0.85	0.91	-0.37	0.63	0.77	0.81	0.88	0.9	0.97	0.93	0.88
Current Deferred Revenue	0.96	0.79	0.84	0.72	0.95	0.66	0.91		0.75	0.96	0.75	0.75	0.96	0.63	0.89	0.74	0.97	-0.53	0.73	0.73	0.84	0.92	0.84	0.95	0.94	0.85
Net Debt	0.73	0.53	0.71	0.65	0.64	0.58	0.61	0.75		0.67	0.71	0.37	0.78	0.48	0.79	0.37	0.79	-0.09	0.33	0.4	0.69	0.8	0.69	0.6	0.8	0.51
Retained Earnings	0.98	0.81	0.86	0.8	0.99	0.59	0.97	0.96	0.67		0.8	0.81	0.98	0.76	0.89	0.8	0.96	-0.46	0.72	0.74	0.79	0.94	0.89	0.98	0.94	0.84
Accounts Payable	0.76	0.52	0.57	0.83	0.77	0.75	0.72	0.75	0.71	0.8		0.44	0.8	0.84	0.68	0.43	0.83	-0.41	0.72	0.29	0.45	0.88	0.64	0.74	0.74	0.42
Cash	0.86	0.91	0.79	0.61	0.85	0.23	0.85	0.75	0.37	0.81	0.44		0.8	0.51	0.86	1.0	0.66	-0.3	0.48	0.81	0.79	0.6	0.88	0.86	0.85	0.85
Non Current Assets Total	0.99	0.83	0.89	0.84	0.98	0.6	0.95	0.96	0.78	0.98	0.8	0.8		0.72	0.95	0.8	0.96	-0.38	0.65	0.73	0.82	0.93	0.92	0.96	0.98	0.84
Non Currrent Assets Other	0.71	0.43	0.46	0.73	0.73	0.65	0.73	0.63	0.48	0.76	0.84	0.51	0.72		0.6	0.51	0.71	-0.28	0.61	0.28	0.41	0.79	0.57	0.7	0.66	0.36
Long Term Debt	0.96	0.89	0.89	0.8	0.9	0.48	0.88	0.89	0.79	0.89	0.68	0.86	0.95	0.6		0.85	0.85	-0.24	0.5	0.73	0.86	0.82	0.95	0.88	0.99	0.82
Cash And Short Term Investments	0.85	0.91	0.79	0.61	0.84	0.23	0.85	0.74	0.37	0.8	0.43	1.0	0.8	0.51	0.85		0.66	-0.29	0.48	0.81	0.79	0.59	0.88	0.85	0.84	0.84
Net Receivables	0.94	0.7	0.84	0.73	0.94	0.65	0.91	0.97	0.79	0.96	0.83	0.66	0.96	0.71	0.85	0.66		-0.43	0.68	0.68	0.8	0.99	0.82	0.92	0.91	0.78
Common Stock Total Equity	-0.39	-0.43	-0.17	-0.26	-0.47	-0.54	-0.37	-0.53	-0.09	-0.46	-0.41	-0.3	-0.38	-0.28	-0.24	-0.29	-0.43		-0.91	-0.16	-0.26	-0.41	-0.23	-0.52	-0.3	-0.27
Common Stock Shares Outstanding	0.65	0.58	0.4	0.55	0.71	0.72	0.63	0.73	0.33	0.72	0.72	0.48	0.65	0.61	0.5	0.48	0.68	-0.91		0.3	0.42	0.68	0.48	0.75	0.57	0.43
Short Term Investments	0.77	0.7	0.83	0.46	0.78	0.11	0.77	0.73	0.4	0.74	0.29	0.81	0.73	0.28	0.73	0.81	0.68	-0.16	0.3		0.75	0.58	0.77	0.79	0.74	0.95
Non Current Liabilities Total	0.85	0.8	0.86	0.41	0.79	0.33	0.81	0.84	0.69	0.79	0.45	0.79	0.82	0.41	0.86	0.79	0.8	-0.26	0.42	0.75		0.74	0.85	0.79	0.87	0.83
Inventory	0.91	0.64	0.79	0.75	0.91	0.69	0.88	0.92	0.8	0.94	0.88	0.6	0.93	0.79	0.82	0.59	0.99	-0.41	0.68	0.58	0.74		0.78	0.89	0.88	0.69
Other Current Assets	0.94	0.93	0.96	0.74	0.9	0.29	0.9	0.84	0.69	0.89	0.64	0.88	0.92	0.57	0.95	0.88	0.82	-0.23	0.48	0.77	0.85	0.78		0.88	0.95	0.85
Other Stockholder Equity	0.98	0.85	0.85	0.77	1.0	0.54	0.97	0.95	0.6	0.98	0.74	0.86	0.96	0.7	0.88	0.85	0.92	-0.52	0.75	0.79	0.79	0.89	0.88		0.93	0.87
Total Liab	0.99	0.88	0.91	0.8	0.94	0.53	0.93	0.94	0.8	0.94	0.74	0.85	0.98	0.66	0.99	0.84	0.91	-0.3	0.57	0.74	0.87	0.88	0.95	0.93		0.84
Property Plant And Equipment Gross	0.87	0.8	0.89	0.56	0.87	0.23	0.88	0.85	0.51	0.84	0.42	0.85	0.84	0.36	0.82	0.84	0.78	-0.27	0.43	0.95	0.83	0.69	0.85	0.87	0.84

Click cells to compare fundamentals

Omnicell Account Relationship Matchups

Omnicell fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.2B	1.8B	2.1B	2.2B	2.2B	2.3B
Short Long Term Debt Total	100.7M	516.1M	528.1M	616.7M	614.1M	644.8M
Other Current Liab	89.7M	113.4M	179.4M	344.7M	310.1M	325.6M
Total Current Liabilities	237.0M	276.4M	876.2M	428.4M	367.8M	386.2M
Total Stockholder Equity	845.3M	967.5M	1.1B	1.1B	1.2B	1.2B
Other Liab	57.9M	64.5M	79.7M	46.2M	53.1M	33.7M
Property Plant And Equipment Net	110.4M	114.2M	119.7M	132.0M	133.6M	140.3M
Current Deferred Revenue	90.9M	100.1M	112.2M	118.9M	132.3M	138.9M
Net Debt	(26.5M)	30.2M	179.0M	286.4M	146.1M	153.4M
Retained Earnings	258.8M	290.7M	368.6M	390.7M	370.4M	388.9M
Accounts Payable	46.4M	40.3M	71.5M	63.4M	45.0M	25.0M
Cash	127.2M	485.9M	349.1M	330.4M	468.0M	491.4M
Non Current Assets Total	757.6M	995.1M	1.4B	1.3B	1.3B	1.4B
Non Currrent Assets Other	151.9M	176.2M	191.3M	164.5M	64.4M	52.5M
Long Term Debt	135.4M	50M	467.2M	566.6M	569.7M	598.1M
Cash And Short Term Investments	127.2M	485.9M	349.1M	330.4M	468.0M	491.4M
Net Receivables	218.4M	190.1M	240.9M	299.5M	263.9M	277.1M
Common Stock Total Equity	51K	53K	54K	55K	49.5K	47.0K
Common Stock Shares Outstanding	42.9M	43.7M	47.9M	45.9M	45.2M	36.4M
Liabilities And Stockholders Equity	1.2B	1.8B	2.1B	2.2B	2.2B	2.3B
Non Current Liabilities Total	158.6M	580.6M	119.6M	652.2M	670.1M	703.6M
Inventory	108.0M	96.3M	119.9M	147.5M	110.1M	115.6M
Other Current Assets	15.2M	57.1M	70.8M	104.4M	85.6M	89.9M
Other Stockholder Equity	595.9M	682.3M	786.5M	756.4M	832.0M	873.6M
Total Liab	395.6M	857.0M	995.8M	1.1B	1.0B	1.1B
Property Plant And Equipment Gross	110.4M	114.2M	119.7M	132.0M	273.0M	286.7M
Total Current Assets	483.2M	829.4M	780.7M	881.8M	927.6M	973.9M
Accumulated Other Comprehensive Income	(9.4M)	(5.5M)	(8.4M)	(17.1M)	(13.4M)	(14.1M)
Short Term Debt	10.1M	(55.4M)	501.1M	10.8M	10.5M	10.0M
Common Stock	51K	53K	54K	55K	56K	53.2K
Property Plant Equipment	54.2M	59.1M	119.7M	94.0M	108.1M	113.5M
Other Assets	100.7M	268.5M	225.6M	139.0M	159.8M	167.8M
Good Will	336.5M	499.3M	738.9M	734.3M	735.8M	772.6M
Intangible Assets	124.9M	168.2M	277.6M	242.9M	277.8M	291.7M
Net Tangible Assets	845.3M	967.5M	130.2M	153.0M	175.9M	297.7M
Retained Earnings Total Equity	258.8M	290.7M	368.6M	390.7M	449.3M	471.8M
Capital Surpluse	780.9M	920.4M	1.0B	1.0B	1.2B	729.3M
Deferred Long Term Liab	39.1M	4.3M	51.7M	2.1M	1.9M	1.8M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Omnicell is a strong investment it is important to analyze Omnicell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omnicell's future performance. For an informed investment choice regarding Omnicell Stock, refer to the following important reports:

How To Invest In Omnicell

Details

Is Omnicell Stock a good investment?

Details

What is Omnicell's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.

You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.558

Earnings Share

(0.39)

Revenue Per Share

23.218

Quarterly Revenue Growth

(0.05)

Return On Assets

(0.01)

The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Omnicell Deferred Long Term Liab vs Capital Stock Analysis

Deferred Long Term Liab vs Capital Stock

Deferred Long Term Liab vs Capital Stock Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Capital Stock

Omnicell fundamental ratios Correlations

Omnicell Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Omnicell fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Stockholder Equity	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity

Common Stock Shares Outstanding	- 0.91	Common Stock Total Equity
Common Stock Total Equity	- 0.54	Other Liab
Common Stock Total Equity	- 0.53	Current Deferred Revenue
Other Stockholder Equity	- 0.52	Common Stock Total Equity
Common Stock Total Equity	- 0.47	Total Stockholder Equity
Common Stock Total Equity	- 0.46	Retained Earnings